Doctor profile · Federal record
Dr. Charlene Farthing, P.A.-C
Physician Assistant · Norton, VA
- NPI 1679627434
- Accepts Medicare
- MIPS 85.2 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
280 Virginia Ave Ne, Suite 106
Norton, VA 242731538
(276) 365-8071
fax (949) 862-3723
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- February 26, 2014
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Virginia #0010-003809
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679627434. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,149
Distinct HCPCS
10
Medicare allowed
$174,283
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 4,600 | 14 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,188 | 248 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 786 | 623 | $72 | |
17000 |
Destruction of precancer skin growth, 1 growth | 412 | 336 | $37 | |
17110 |
Destruction of skin growth, 1-14 growths | 383 | 324 | $86 | |
11102 |
Biopsy of related skin growth, first growth | 218 | 204 | $65 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 153 | 153 | $87 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 89 | 42 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 53 | 42 | $98 | |
11103 |
Biopsy of related skin growth, each additional growth | 52 | 38 | $38 |
In context: peer comparison
Among 3 peers in Norton Physician Assistant, average services per provider: 254. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$653
Transactions
30
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | 5 | $163.68 | |
| Amgen INC. | 4 | $92.96 | |
| Incyte Corporation | 3 | $62.04 | |
| Novartis Pharmaceuticals Corporation | 3 | $61.57 | |
| Sun Pharmaceutical Industries INC. | 3 | $60.45 | |
| Dermavant Sciences, INC. | 3 | $55.15 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $39.06 | |
| Abbvie INC. | 2 | $29.84 | |
| Lilly USA, LLC | 2 | $26.55 | |
| Tactile Systems Technology INC | 1 | $25.94 | |
| Janssen Biotech, INC. | 1 | $19.37 | |
| Ucb, INC. | 1 | $16.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
905
Patients
651
Total drug cost
$164,421
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 173 | 117 | $8,649 |
| Ketoconazole | Generic | 150 | 107 | $4,794 |
| Triamcinolone Acetonide | Generic | 138 | 113 | $1,781 |
| Hydrocortisone | Generic | 101 | 81 | $867 |
| Mometasone Furoate | Generic | 65 | 51 | $2,292 |
| Mupirocin | Generic | 54 | 49 | $536 |
| Imiquimod | Generic | 39 | 31 | $1,839 |
| Betamethasone Dipropionate | Generic | 32 | 24 | $1,841 |
| Doxycycline Hyclate | Generic | 31 | 19 | $922 |
| Hydroxyzine Hcl | Generic | 25 | 11 | $308 |
Frequently asked questions
What is Dr. Charlene Farthing's medical specialty?
Dr. Charlene Farthing practices Physician Assistant in Norton, VA.
Where does Dr. Charlene Farthing practice?
Dr. Charlene Farthing practices at 280 Virginia Ave Ne, Norton, VA 242731538. Office phone: 2763658071.
What is Dr. Charlene Farthing's NPI?
Dr. Charlene Farthing's National Provider Identifier (NPI) is 1679627434, issued by NPPES.
Does Dr. Charlene Farthing accept Medicare assignment?
Yes. Dr. Charlene Farthing accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charlene Farthing commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.